Humankind faces a crisis of non-communicable chronic diseases that encompass pathologies such as obesity (and its co-morbidities), inflammatory bowel diseases, allergies, and autoimmune diseases. Microbiome alterations (dysbioses) induced through lifestyle and diet have been implicated in this development. There is tremendous potential for the targeted modulation and restoration of gut microbiota composition and functionality to combat chronic diseases. 

In this Webinar, Prof. Jens Walter (APC Microbiome Ireland, University College Cork) and Andrea Doolan, CEO at Atlantia Clinical Trials will discuss:

• The latest innovations in the area of nutrition and functional ingredients that enable a targeted and health-oriented modulation and/or restoration of gut microbiome composition and function. 
• Advances in our ecological and mechanistic understanding of how dietary components interact with the gut microbiota in relation to health do now provide a solid foundation for the rational design of food products and medical foods for tangible health outcomes. 

Prof. Walter and Andrea Doolan will discuss how the partnership between the APC Microbiome Ireland and Atlantia provides a powerful translational pipeline that ranges from the discovery of microbiome features that are medically relevant in specific conditions, the design of nutritional approaches to target these features, and the clinical validation of these approaches using disease-specific surrogate endpoints.